COHR delivered a clean earnings beat after the close on May 6, and the numbers arrived just as a wave of analyst upgrades had already begun repricing the stock.
Fiscal Q3 revenue came in at $1.806 billion, ahead of the $1.780 billion consensus. Adjusted EPS of $1.41 edged past the $1.40 estimate. Q4 guidance was equally reassuring — the company guided for revenue of $1.910–$2.050 billion and adj. EPS of $1.52–$1.72, bracketing consensus on both lines. The stock had already rallied 10.4% on the week heading into the print, climbing to $335.73 on May 5, up 30% over the prior month alone. The earnings result adds a fresh confirmation layer to a run that was already well underway.
The analyst community spent the past two weeks positioning ahead of the result, and the direction was unambiguously bullish. Stifel's Ruben Roy lifted his target from $275 to $412 just one day before the print while keeping his Buy rating — the most recent and most aggressive move in the coverage universe. On May 1, Rothschild initiated with a Buy and a $455 target, the highest on the Street. Citi raised to $420 from $250 in late April, and JPMorgan moved to $300 from $245 in early April. Morgan Stanley stayed on the sidelines with an Equal-Weight but nonetheless raised its target from $250 to $290. The mean price target of $326.78 now sits modestly below the current share price — though with the Stifel, Citi, and Rothschild targets clustered above $410, the consensus figure is likely to move higher as firms update post-print. Factor scores reinforce the bullish lean: the analyst recommendation differential ranks in the 93rd percentile relative to the broader universe, one of the strongest signals in the dataset.
The bear case is structural rather than near-term. Coherent is building out what it describes as the largest organic indium phosphide capacity expansion in the industry — a 90% increase over four years, alongside a shift to 6-inch wafer production that is expected to roughly quadruple InP output. Bulls see that as a durable AI-optics moat. Bears note limited InP capacity relative to larger competitors, plus FX exposure and debt load. The valuation has stretched to reflect the optimism: the trailing P/E is now running near 55x, up roughly 12 points over the past 30 days, and EV/EBITDA is above 36x. The earnings-yield factor ranks in just the 7th percentile — stretched, but not unusual for a company where forward EPS momentum is accelerating. The EPS momentum scores at the 70th and 72nd percentile over 30- and 90-day windows respectively suggest estimate revisions are still moving in the right direction.
Short positioning reads as an afterthought in this context. Short interest as a percentage of the free float has compressed steadily, from above 6.2% in late March to roughly 4.97% by May 5 — a multi-week unwind that predates and reinforces the price move. Borrowing costs are negligible at 0.27%, down 7% on the week, and lending availability is loose, pointing to no meaningful squeeze dynamics. The ORTEX short score is 35.5, close to the bottom of the short-pressure range and drifting lower over the past two weeks. Options positioning tells a slightly more cautious tale — the put/call ratio is running at 1.01, just above its 20-day average of 0.97 and near the midpoint of its 52-week range — but given the magnitude of the analyst upgrades and the earnings beat, that barely registers as a hedge signal.
Among correlated peers, BELF.A led on the week with a 16% gain, while KEYS and LFUS also outperformed with gains of 7.1% and 8.6% respectively, suggesting electronic-components names broadly caught a bid. AEIS was a notable outlier, down 6.4% on the week, while FN slipped 8% on Wednesday alone despite a 3.5% weekly gain — a reminder that individual execution still matters in this peer group even in a rising tape.
The focus now turns entirely to management's commentary on the earnings call — specifically the trajectory of InP capacity ramps, datacom versus AI transceiver mix, and whether the Q4 guidance midpoint of $1.98 billion in revenue reflects conservatism or a genuine plateau in demand.
See the live data behind this article on ORTEX.
Open COHR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
